Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Notification of holding of treasury shares
Company announcement – No. 42 / 2026 Zealand Pharma – Notification of holding of treasury shares Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Why The Next Winners In Beauty Are More Pharma Than Cosmetics
Demi Moore wins the Best Performance by a Female Actor in a Motion Picture - Musical or Comedy award for 'The Substance' during the 82nd Annual Golden Globes. The film portrays Moore as an aging celebrity who goes to extreme lengths to retain her…
Why AI-Driven Drug Discovery Is Becoming Pharma's Next Big Bet
AI is not replacing scientific intuition but rather enhancing early-stage research. My first two years of college were in a special medical school program focused on the courses required to get into a pharmacy program, to become a pharmacist.
TME Pharma provides update on its activities
TME Pharma provides update on its activities TME Pharma enters the final evaluation phase of advanced discussions with two potential partners for a license agreement. Discussions and potential partnership are aimed at enabling the further…
Snoring, subways and stealth ads: how big pharma targets China's waistline
Weight-loss drugmakers, vying to tighten the belts of Chinese consumers, are promoting obesity awareness in metro stations, exercise studios and soccer stadiums as local restrictions prevent the direct advertising of prescription medicines in the…
Chinese tech, pharma firms eye Hong Kong as springboard for global expansion
Mainland Chinese technology and pharmaceutical companies are using Hong Kong as a launching pad for global expansion, industry leaders have said, as a major state-owned drugmaker weighs whether to invest in the city's Northern Metropolis…
Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)
Company announcement No. 41 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 34, 2026) Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
InnoCare Pharma Limited (INCPF) Q2 2026 Earnings Call Transcript
InnoCare Pharma Limited (INCPF) Q2 2026 Earnings Call August 24, 2026 8:30 AM EDT Jisong Cui - Co-Founder, Chairwoman & CEO Xin Fu - Chief Financial Officer Renbin Zhao - Senior VP of Clinical Development & Medical Research and Executive Director…
Big pharma's next $10 billion gamble: Ozempic for your brain
A new wave of treatments for a rare illness are being touted as the next major breakthrough from the same class of drugs as Ozempic, sparking multibillion-dollar acquisitions from pharmaceutical giants but caution from experts who warn that more…
How big pharma targets obesity in China's weight-loss market
SHANGHAI – Weight-loss drugmakers, vying to tighten the belts of Chinese consumers, are promoting obesity awareness in metro stations, exercise studios and soccer stadiums as local restrictions prevent the direct advertising of prescription…
CBN, PHARMEXCIL sign MoU to boost pharmaceutical exports
The Central Bureau of Narcotics (CBN) under the finance ministry and the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), set up by the Ministry of Commerce and Industry, on Monday signed an agreement to boost exports of pharma…
US price pressure 'threatens new drugs' in Switzerland
In an interview with Swiss public broadcaster SRF, Buholzer also warns that price pressure from the United States is preventing new drugs from being developed in Switzerland. SRF: Why does such a powerful industry need political support from a…
Telix Pharmaceuticals: Execution Is The Name Of The Game Here (NASDAQ:TLX)
Telix Pharmaceuticals has rebounded strongly, reaching profitability and guiding FY2026 revenue to $950–$970 million, driven by precision medicine sales. Key catalysts include imminent FDA decisions for TLX101-Px (brain tumor imaging) and…
Why Hospital Prices Keep Rising-And How Competition Can Help
“For years, lawmakers in both parties have disproportionately focused on prescription drug prices,” says health expert Sally Pipes. “The latest inflation data suggest it's time to shift that focus.” Prescription drug…
Mortgage REITs Yield Up To 18%: Buy Rithm And Annaly, Avoid Dynex And Armour
Rithm Capital offers the best combination of strong dividend coverage (2.4x) and a substantial discount to book value (~0.82x). Annaly Capital earns a Buy rating for its consistent dividend coverage and improving fundamentals, despite trading above…
Receive a Daily briefing on Pharma Industry News
Get Started